Oncology Research and Treatment

Article	Citations
Follow-Up Time of Anal Cancer Screening among Women Living with HIV at High Risk of Developing Anal Cancer	27
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2023	26
uGI: Biomaker-Cut-Offs in der Immunonkologie	22
Front & Back Matter	18
PharmaNews	10
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience	9
ED- und LD-SCLC: Studienergebnisse zum Einsatz von Durvalumab	9
Body Composition and Inflammation as Emerging Sex-Specific Prognostic Factors in Patients with Advanced Cutaneous Melanoma Undergoing Immune Checkpoint-Inhibition Therapy: A Prospective Pilot Study	8
High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study	8
Aggressive B-Cell Lymphoma with Metastatic Spinal Cord Compression: Treat the Patient, Not the Disease	8
EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis	8
Society Bulletins	8
Intradermal Naked DNA Vaccination by DNA Tattooing for Mounting Tumor-Specific Immunity in Stage IV Melanoma Patients: A Phase I Clinical Trial	7
Career and Professional Development for Young Oncologists	7
Health Economic Aspects of Platelet Concentrates: Comparing Cost and Reimbursement of Pathogen Inactivated and Conventional Platelet Concentrates in a German Comprehensive Cancer Center	7
Hochrisiko-MDS: Therapeutischer Ansatzpunkt Immunsystem	7
Prognosis and Therapy of Ovarian Cancer, Part 1: Patient Selection and Surgical Management in Advanced Ovarian Cancer – What Tools Do We Have to Make the Right Decision?	7
PharmaNews	6
Liquid Biopsy in Metastatic Breast Cancer: Path to Personalized Medicine	5
Editing for Cure: in Conversation with Sylvie Lorenzen and Ralf-Dieter Hofheinz	5
DKK 2024: Acalabrutinib im Praxis-Check	5
OnkoImmun 21	5
Front & Back Matter	5
PharmaNews	5
Society Bulletins	5

PharmaNews	5
Guidelines of Onkopedia: What Is New? Locally Advanced Rectal Cancer	5
Real-World Survival Outcomes in Patients with Different Types of Cancer Managed with Immune Checkpoint Inhibitors	4
Erratum	4
PharmaNews	4
PharmaNews	4
Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report	4
Evaluating the Benefits and Challenges of Using Patient Preferences as a Tool for Clinical Decision Making in Oncology Multidisciplinary Team Meetings within the National Health Service: A Qualitative	4
Tumor-Infiltrating Lymphocytes, CAR-, and T-Cell Receptor-Modified T Cells in Solid Cancer Oncology	4
Vorwort des DGHO-Vorstands	4
Society Bulletins	4
Capivasertib/Fulvestrant bei ER+/HER2– MBC	4
Spirituality in Oncology: Relations between Spirituality, Its Facets, and Psychological and Demographic Factors in Cancer Patients in Germany	4
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients	4
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial	4
Epcoritamab: Indikationserweiterung für das FL	4
Pirtobrutinib: Nicht-kovalente BTKi-Therapieoption beim MCL	3
Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer	3
Modifications to Prostate Cancer Diagnosis following COVID-19 and Following Models	3
Prognosis and Therapy of Ovarian Cancer: Part 2 – the Shifting Landscape of Medical Treatment in Ovarian Cancer	3
Multiples Myelom: Langzeitergebnisse der MAIA-Studie	3
A Current Assessment of the Use of Complementary Medicine in German Cancer Patients: The CONKO 022 Investigation	3
Safety and Efficacy of Pharmacotherapy Containing the Second-Generation Integrase Inhibitors and Chemotherapy Drugs in AIDS-Related Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Analysi	3
Interview mit Prof. Paul G. Richardson, Boston, zu Melflufen	3
Society Bulletins	3
Survivorship in Chimeric Antigen Receptor T-Cell Therapy Recipients: Infections, Secondary Malignancies, and Non-Relapse Mortality	3
Management of Advanced Penile Cancer	3
ASH-Daten zu Wirksamkeit und Sicherheit von Teclistamab beim RRMM	3
Erstlinien-IO-IO-Regime: 4-Jahres-OS-Rate bei 25%	3
Psychological Stress in Breast Cancer Patients during the Course of a Pandemic Disease: Before and after the Availability of Vaccines	3
Management of Patients Undergoing CAR-T Cell Therapy in Germany	2
Geriatric Assessment Scale for Optimal Management of Gastric Cancer in Older Adults Who Underwent Gastrectomy: A Systematic Review	2
ONKOPEDIA Guideline Updates “in a Nutshell” for the Readers of Oncology Research and Treatment	2
Identification and Validation of Cyclin A2 and Cyclin E2 as Potential Biomarkers in Small Cell Lung Cancer	2
Acknowledgement to Reviewers	2
Poor Outcome of Adult T-Cell Leukemia/Lymphoma with Current Available Therapy: An Experience of Two Centers	2
Factors Associating with Bone-Only Metastasis in Chinese Breast Cancer Patients in the Absence of Anti-Human Epidermal Growth Factor Receptor 2-Targeted Therapy	2
HCC - Frühzeitiges Erkennen ermöglicht rasche und effektive Therapie	2
PharmaNews	2
Society Bulletins	2
Society Bulletins	2
Perspectives for Cancer Care and Research in Central and Eastern Europe	2
Nomogram Based on the Dynamic Change in the Neutrophil-to-Lymphocyte Ratio for Predicting the Pathological Complete Response of Breast Cancer after Neoadjuvant Systemic Therapy	2
Editing for Cure: In Conversation with Marie von Lilienfeld-Toal and Kathrin Heinrich	2
Guidelines of Onkopedia: What Is New?	2
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023	2
Erweiterte Therapieoptionen bei EGFRm NSCLC	2
Front & Back Matter	2
OnkoImmun 19	2
Oncology in Europe	2

Early versus Delayed Tumor-Specific Therapy and Survival in Patients with Lung Cancer: A Retrospective Study	2
Implementation of Communication Skills Training at Oncology Centers in Germany: Results of a Mixed-Methods Survey	2
Prelims	2
Front & Back Matter	2
Society Bulletins	1
Leitlinien-Updates: Lorlatinib ist präferierter 1L-Standard beim ALK+ aNSCLC	1
Beta-Thalassämie und Sichelzellkrankheit: Nutzenerfolg mit Exa-cel	1
Onkologische Patient*innen individuell behandeln und begleiten	1
Navigating the Evolving Landscape of Advanced Genitourinary Cancer Treatment	1
PharmaNews	1
Prelims	1
Ovarian Cancer and Its Association with Endometriosis: A Narrative Review	1
Moving tumor-agnostic therapy to the big stage – translational and molecular oncology highlights from the ESMO Congress 2025	1
Society Bulletins	1
Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other Countries	1
Stability of End-of-Life Care Wishes and Gender-Specific Characteristics of Outpatients with Advanced Cancer under Palliative Therapy: A Prospective Observational Study	1
AbbVie: BioPharma-Unternehmen mit onkologischer Mission	1
Stereotactic Radiotherapy in Early-Stage Breast Cancer in Neoadjuvant and Exclusive Settings: A Systematic Review	1
PharmaNews	1
Adverse Effects and Functional Outcome after Salvage Lymph Node Dissection in Prostate Cancer	1
Front & Back Matter	1
Contents Vol. 47, 2024	1
Society Bulletins	1
Disease Burden of Colorectal Cancer in China from 1990 to 2019: Age- and Sex-Specific Time Trends and 10-Year Forecast	1
Impact of Epidural Anesthesia on the Outcome of Elderly Patients with Endometrial Cancer: Results of a Propensity Score-Matched Analysis	1
Quality Measurement for Soft Tissue Sarcomas in Germany: First Results of the Certified Sarcoma Centres	1
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2022	1
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Targeted Therapies	1
Real-World Advances in Metastatic Pancreatic Cancer Treatment in the Pre-Molecular Era: A Retrospective Single-Center Analysis 2010–2018	1
The Leucine-Rich α2-Glycoprotein-1 Levels in Patients with Multiple Myeloma	1
Enhanced Survival with Lymphadenectomy in Early-Stage Metachronous Second Primary Lung Cancer: A Retrospective Analysis	1
Prognostic Significance of HER2 Positivity in Endometrium Cancer	1
OnkoImmun 18	1
Improving Accuracy and Source Transparency in Responses to Soft Tissue Sarcoma Queries Using GPT-4o Enhanced with German Evidence-Based Guidelines	1
Clinical Prognostic Significance of LRG1 in Metastatic Breast Cancer	1
Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database	1
Society Bulletins	1
Epidemiology, Real-World Treatment Patterns, and Patient Outcomes of Primary Advanced or Recurrent Endometrial Cancer in Germany between 2015 and 2021	0
Machine Learning-Based Prognostic Modeling of Seven Signatures Associated with Lysosomes for Predicting Prognosis and Immune Status in Clear Cell Renal Cell Carcinoma	0
PharmaNews	0
The Path to Clinical Implementation of DPYD Pharmacogenetic Testing: Long-Term Experience from an External Quality Assessment Provider and a University Testing Center	0
Systematic Evaluation of Vitamin D and the Risk of Breast Cancer Development	0
Laser Interstitial Thermal Therapy in a Large Thalamic Glioma with Long-Term Remission: A Case Report	0
Management of Oligometastatic Disease in Esophagogastric Cancer: What Is the Evidence?	0
The Effect of Positron Emission Tomography-Computed Tomography Parameters on Pathological Response in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvan	0
PharmaNews	0
Ambulatory Routine Care in Oncology in Germany: Real-World Survival Data	0
Society Bulletins	0
2025 ASCO Bladder Cancer Highlights	0
CONKO-011/AIO-SUP-0115/ass.: Rivaroxaban Compared to Low Molecular Weight Heparin in Cancer Patients with Acute Venous Thromboembolism	0
Safety of Surgery within 24 h following Colonoscopy for Colorectal Cancer: A Retrospective Propensity Scores Matched Analysis	0
(Un-)Known Chances: Emerging Hope for Cancer of Unknown Primary - Highlights from ESMO 2025 and the first International Cancer of Unknown Primary Meeting	0
Managing Antithrombotic Treatment in Patients with Immune Thrombocytopenia	0
Structured Magnetic Resonance Imaging Assessment Improves Diagnosis of Pathological Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation	0
Paraneoplastic Papillitis as a Precursor to Colon Carcinoma: A Case of Unexpected Vision Loss Leading to Early Cancer Detection	0
COVID-19 in Patients with Active Cancer: Higher Inflammatory Activity Predicts Poor Outcome	0
Society Bulletins	0
Mucinous Cystadenocarcinoma of the Breast with Bone Metastases: First Case Report and Literature Review	0
Neu bei mCRPC: Talazoparib + Enzalutamid	0
PharmaNews	0
Front & Back Matter	0
Osimertinib: Hohe Wirksamkeit im Zentralnervensystem	0
Differential Expression of Immune Checkpoints TIM-3, LAG-3, TIGIT, and Siglec-7 on Circulating Natural Killer Cells – Insights from Healthy Donors Compared to Gastric Cancer Patients	0
PharmaNews	0
Treatment Satisfaction and Treatment Wishes of Patients with Chronic Cancer-Related Pain	0
Evaluation of the Impact of Adaptive Progressive Supervised Resistance Training on Strength and Quality of Life in Patients with Breast Cancer during Chemotherapy: The VALESCO Study	0
A Comprehensive Review of Epidermal Growth Factor Receptor Mutation Abundance in Non-Small Cell Lung Cancer Treated with Tyrosine Kinase Inhibitors	0
Momelotinib bei Myelofibrose und Anämie	0
Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie	0
Society Bulletins	0
Society Bulletins	0
No Survival Differences among Germ-Cell Cancer Patients from Urban and Rural Areas	0
Frontline Pembrolizumab or Methotrexate in Elderly, Frail, or Cisplatin-Ineligible Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck: Results of the Randomized Phase 2	0
Fortgeschrittenes oder nicht resezierbares HCC: explorative 4-Jahres-Analyse STRIDE	0
Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Pat	0
Before-and-after Studies in Oncology: How Real Is the Real-World Evidence?	0
KRAS Inhibition in Non-Small Cell Lung Cancer with Central Nervous System Involvement: Current Evidence and Future Directions	0
mNSCLC - Leitlinie empfiehlt POSEIDON-Regime	0
Comparison of the Efficacy, Safety, and Quality of Life of Pegylated Liposomal Doxorubicin-Cyclophosphamide versus Epirubicin-Cyclophosphamide in Patients with Early-Stage HER2-Negative Breast Cancer:	0
Patient-Reported Outcome in Metastatic Breast Cancer and Platinum-Resistant Recurrent Ovarian Cancer Patients Treated with Metronomic Cyclophosphamide ± Methotrexate: PROmetronomic	0

Variable Outcomes of Hepatitis E Infections in Patients with Hemato-Oncologic Diseases	0
Treatment of Advanced or Metastatic Urothelial Cancer	0
Oncolytic Activity of Canine Distemper Virus in Human Ductal Breast Carcinoma Cells	0
Thoracic Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023 with Focus on Perioperative Therapy, Radiotherapy, and Bispecific T-Cell Engagers	0
Albert Schweitzer, Chronic Myeloid Leukemia, and War	0
Use of Follow-Up Psycho-Oncology Consultations in Urological Cancer after Transition from Inpatient to Outpatient Care	0
Hypogammaglobulinemia and Anti-CD20 Therapy-Induced Acute Thrombocytopenia: Perhaps More than a Coincidence?	0
Combination Therapy Consisting of Transarterial Chemoembolization, Lenvatinib, and Programmed Cell Death Protein 1 Blockade for Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombus: A Case	0
Society Bulletins	0
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114)	0
The Diagnostic Utility of cfDNA and ctDNA in Liquid Biopsies for Gastrointestinal Cancers over the Last Decade	0
What is new in the German S3 guideline on gastric cancer: diagnosis, staging and treatment	0
PharmaNews	0
Exercise as Medicine Could Be a Chance for Early Detection and Prevention of Cardiotoxicity in Cancer Treatments: A Narrative Review	0
The Critical Role of Sex and Gender in Medicine	0
Navigating Gynecological Oncology with Different Versions of ChatGPT: A Transformative Breakthrough or the Next Black Box Challenge?	0
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation	0
Preferences on Treatment Decision Making in Sarcoma Patients: Prevalence and Associated Factors – Results from the PROSa Study	0
Geriatric Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2024	0
Palliative Care for the Management of Patients with Allogeneic Hematopoietic Stem-Cell Transplantation: A Cross-Sectional Survey in Comprehensive Cancer Centers	0
Chemoimmuntherapie als ein Standard bei ED-SCLC	0
Verlässliche Immuntherapie in der Versorgungsrealität	0
Prelims	0
Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer	0
Retraction Statement	0
Assessment and Evaluation of Psychosocial Distress in Outpatients with Cancer at a University Hospital in Germany	0
Erstmals 3-Jahres-Daten bei biliären Karzinomen	0
PharmaNews	0
PharmaNews	0
Abemaciclib beim eBC und mBC	0
Psycho-Oncological Self-Help Groups in Bavaria: The Current Situation and Suggestions for Improvement	0
Effect of Early Tumor Shrinkage and Depth of Response on the Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization and Lenvatin	0
Pancreatic Cancer Highlights from the European Society for Medical Oncology Annual Meeting 2024 in Barcelona	0
Clinical Features, Treatment Modalities, and Outcomes of Elderly Thymoma Patients: A Propensity-Matched Study Based on the SEER Database	0
Sacituzumab govitecan beim fortgeschrittenen Mammakarzinom	0
Supportive Therapie bei Krebs: AGSMO Jahreskongress 2025, 24. Mai 2025, Berlin und online – Abstracts	0
Evaluating the Impact of Age and G8 Assessment on Definitive Treatment Strategies in Elderly Patients with Local Advanced Esophageal Carcinoma	0
Asciminib: Wirksamkeit & Verträglichkeit im Langzeitverlauf	0
Changes in Tumor Immune Microenvironment after Radiotherapy Resistance in Colorectal Cancer: A Narrative Review	0
Society Bulletins	0
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie. 13. bis 16. Oktober 2023, Hamburg: Abstracts	0
Onkopedia: What’s New? Systemic Tumor Treatment in Pregnancy	0
Gastroesophageal Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023	0
Society Bulletins	0
Society Bulletins	0
Melflufen: Therapieoptionen beim Multiplen Myelom	0
r/r DLBCL: Heilungschance mit Axi-Cel	0
Lungenkarzinom: Aktuelle Entwicklungen zur Therapie	0
Real-World-Evidenz für Daratumumab-CyBorD bei AL-Amyloidose	0
Quality of Life and Patient-Reported Outcomes: Highlights from the European Society for Medical Oncology Annual Meeting Congress 2025	0
Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany	0
PharmaNews	0
Durvalumab-Immuntherapie: Dauer beeinflusste Erfolg	0
Treatment Navigation in Breast Cancer Management: Process Cost Analysis Based on German Case Studies	0
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience	0
Effectiveness and Safety of Combining Transarterial Chemoembolization with Tyrosine Kinase and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Meta-Analysis	0
Gender as a Contextual Factor in Quality of Life of Cancer Survivors: A Literature Review	0
Colorectal Cancer Highlights from the European Society for Medical Oncology Annual Meeting 2023	0
Molecular Tissue Profiling in a Clinically Selected Pancreatic Cancer Cohort	0
Total Lymph Node Yield Is Associated with Prolonged Survival after Neoadjuvant Chemotherapy in ypN0 Gastric Cancer Patients	0
Management of Advanced Germ Cell Tumours	0
Cancer-Related Cognitive Dysfunction: A Narrative Review for Clinical Practice	0
Resektabilität bei NSCLC III: Schlüssel zur Therapie	0
EGFR plus MET Targeted Therapies for Overcoming Treatment Resistance in EGFR-Mutant Non-Small Cell Lung Cancer: A Case Report	0
Anti-HER2/Neu Antibody Therapy Inhibits HER2 + Breast Cancer by Blocking Myeloid-Derived Suppressor Cell Activity	0
Associations of Dietary Factors with Cutaneous Melanoma: A Case-Control Study in Greece with Literature Review	0
TACE Combined with Hepatic Arterial Infusion of Nivolumab for Inhibiting Tumor Angiogenesis in Hepatocellular Carcinoma	0
Prelims	0
Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group	0
Effektive Therapieoption: Pegcetacoplan bei PNH	0
Society Bulletins	0
Updated International Guidelines for Survivorship Care after Pediatric Cancer: Practice Implications in a German and Austrian Comprehensive Care Network	0
New Insights from Long-Term Clinical Use of Circulating Tumor DNA-Based Minimal Residual Disease Monitoring in Translocation-Associated Sarcomas	0
Vorteile des MAIA-Regimes bei Hochrisikozytogenetik	0
Highlights from ESMO 2024 as a Young Head and Neck Oncologist	0
Standardizing Nutritional Care for Cancer Patients: Implementation and Evaluation of a Malnutrition Risk Screening	0
Concomitant Irradiation to Checkpoint Inhibitor Therapy of Hepatocellular Carcinoma Patients: A Systematic Retrospective, Single-Center Analysis	0
Anaemia in Hospitalized Cancer Patients: A Retrospective Study of Two Cohorts before and after the Guideline Update	0
Stereotactic Radiotherapy for Penile Metastasis: Case Report and Systematic Literature Review	0
CLL-Therapien: Zeitlich begrenzt und zielgerichtet, langfristig erfolgreich	0
PharmaNews	0
Society Bulletins	0
PharmaNews	0
Palbociclib in Combination with either Aromatase Inhibitors or Fulvestrant for Patients with Advanced HR+/HER2− Breast Cancer in Germany: Final Results of the Phase 2 Multicohort INGE-B Trial	0
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO)	0
PharmaNews	0
Society Bulletins	0
Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment – Recommendations from an Expert Group from Austria, Germany, and Switzerland	0
Immune System Activation in Patients with Metastatic Renal Cell Carcinoma Induced by the Systemic Abscopal Effects of Radiation Therapy	0
PharmaNews	0
A Real-World Evaluation of Brain Imaging in Patients with Advanced Non-Small Cell Lung Cancer: Insights from a German Claims Data Analysis	0
PharmaNews	0
Society Bulletins	0
4-Jahres-Daten der CheckMate-9LA-Studie zum NSCLC	0
Identification of Biomarkers for Cervical Cancer Radiotherapy Sensitivity and Survival Prognosis	0